Vincent Falanga, MD, FACP
Professor
Boston University School of Medicine
Dept of Dermatology

MD, Harvard Medical School



A dedicated researcher, clinician, and educator, Dr. Vincent Falanga has had a longstanding relationship with the Boston University community. For the past 15 years, Dr. Falanga has been a Professor of Dermatology and Biochemistry at the Boston University School of Medicine (BUSM). In addition, he served as the Assistant Dean of Clinical and Faculty Affairs, as well as the Director of the Boston University Medical Students Ambulatory Medical Clerkship at Roger Williams Medical Center (RWMC), a research and clinical affiliate of the BUSM. From 1998 to 2013, he was the Chairman and Program Director of the Department of Dermatology at RWMC. Prior to that, Dr. Falanga held several academic appointments, including an initial one at the University of Pittsburgh School Of Medicine, and then as Professor of Dermatology and Medicine at the Miller School of Medicine at the University of Miami. A graduate of Harvard Medical School, Dr. Falanga received training in Internal Medicine and Dermatology at the University of Miami and the University of Pennsylvania, respectively. He is Board certified in both Medicine and Dermatology. In 2004, he was the President of the Wound Healing Society, the premier research organization in the world dedicated to wound healing.

Vincent Falanga’s remarkable research career began in the fields of molecular and cell biology, evolving over the years to groundbreaking human-based translational research. He made seminal contributions to the expansion and growth of single cells in low oxygen tension and to the effects and transcriptional regulation of transforming growth factor-ß 1 (TGF-ß1). Dr. Falanga later focused his efforts on human recombinant growth factors and was the first to use a recombinant growth factor (EGF) in human non-healing wounds. He showed that systemic anabolic steroids can heal the painful skin ulcers due to cryofibrinogenemia and that doubling the dose of systemically administered pentoxifylline will heal venous ulcers. In 1998, he was the lead author in the use of living bioengineered skin in non-healing wounds, which led to the first ever FDA approval of bioengineered skin for accelerating wound closure. In 2007, he was the first to successfully use autologous cultured bone marrow-derived mesenchymal stem cells in human chronic wounds. In his new role as the Department of Dermatology’s Vice Chair for Research, Dr. Falanga will spearhead and coordinate many of the research projects related to tissue injury, repair processes, and regeneration. The School of Medicine and the Department of Dermatology are currently building a Good Manufacturing Practice (GMP) facility in which Dr. Falanga will oversee the research and development of novel treatments utilizing the therapeutic potential of stem cells in the care of chronic wounds caused by disorders ranging from diabetes to autoimmune disease. The GMP facility promises to enrich the translational capabilities of the Medical Center in Dermatology and other specialties. His current project with stem cells in human wounds is funded by the National Institutes of Health, which has awarded Dr. Falanga more than $45 million over the course of his career.


Treatment of Venous Ulcers with Autologous Cultured Bone Marrow Stem Cells
07/01/2013 - 09/16/2016 (PI)
NIH/National Institute of Arthritis & Mu
5R01AR060342-06

Development of Adult Pluripotent Very Small Embryonic Like (VSEL) Stem Cells to T
09/11/2013 - 02/28/2015 (PI)
Neostem, Inc NIH NIAMS
1R43AR062432-01A1

The use of topically applied bone-marrow derived adult mesenchymal stem cells (MCSs) for rapid wound healing
07/01/2013 - 06/30/2014 (PI)
Neostem, Inc Dept of Defense




Yr Title Project-Sub Proj Pubs
2015 Treatment of venous ulcers with autologous cultured bone marrow stem cells 5R01AR060342-06 10
2014 Treatment of venous ulcers with autologous cultured bone marrow stem cells 5R01AR060342-05 10
2013 Treatment of venous ulcers with autologous cultured bone marrow stem cells 5R01AR060342-03 10
2013 Treatment of venous ulcers with autologous cultured bone marrow stem cells 7R01AR060342-04 10
2012 Treatment of venous ulcers with autologous cultured bone marrow stem cells 5R01AR060342-02 10
2012 New Approaches to Tissue Repair 8P20GM103414-10 10
2011 NEW APPROACHES TO TISSUE REPAIR: ADMINISTRATIVE CORE 5P20RR018757-09-8350 82
2011 Treatment of venous ulcers with autologous cultured bone marrow stem cells 1R01AR060342-01A1 10
2011 New Approaches to Tissue Repair 5P20RR018757-09 82
2010 NEW APPROACHES TO TISSUE REPAIR: ADMINISTRATIVE CORE 5P20RR018757-08-7476 82
Showing 10 of 47 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Grada A, Falanga V. Cryofibrinogenemia-Induced Cutaneous Ulcers: A Review and Diagnostic Criteria. Am J Clin Dermatol. 2017 Feb; 18(1):97-104.View Related Profiles. PMID: 27734332; DOI: 10.1007/s40257-016-0228-y;.
  2. Grada A, Falanga V. Novel Stem Cell Therapies for Applications to Wound Healing and Tissue Repair. Surg Technol Int. 2016 Oct 26; XXIX:29-37.View Related Profiles. PMID: 27728944.
  3. Alani RM, Larson A, Falanga V. Paving a New Path Towards Academic Medicine-A Novel Approach to Graduate Medical Education in the United States. Acad Med. 2016 Aug; 91(8):1039-40.View Related Profiles. PMID: 27465087; DOI: 10.1097/ACM.0000000000001269;.
  4. Mani R, Margolis DJ, Shukla V, Akita S, Lazarides M, Piaggesi A, Falanga V, Teot L, Xie T, Bing FX, Romanelli M, Attinger C, Han CM, Lu S, Meaume S, Xu Z, Viswanathan V. Optimizing Technology Use for Chronic Lower-Extremity Wound Healing: A Consensus Document. Int J Low Extrem Wounds. 2016 Jun; 15(2):102-19. PMID: 27207900; DOI: 10.1177/1534734616646261;.
  5. Fournier JB, Dabiri G, Thomas V, Skowron G, Carson P, Falanga V. Serratia marcescens Bullous Cellulitis in a Splenectomized Patient: A Case Report and Review of the Literature. Int J Low Extrem Wounds. 2016 Jun; 15(2):161-8.View Related Profiles. PMID: 27079487; DOI: 10.1177/1534734616636271;.
  6. Otero-Viñas M, Falanga V. Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy. Adv Wound Care (New Rochelle). 2016 Apr 01; 5(4):149-163. PMID: 27076993.
  7. Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF-ß) isoforms in wound healing and fibrosis. Wound Repair Regen. 2016 Mar; 24(2):215-22.View Related Profiles. PMID: 26704519; DOI: 10.1111/wrr.12398;.
  8. Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH, Thom S, Tomic-Canic M, Walston J, Whitney JA, Williams J, Zieman S, Schmader K. Chronic wound repair and healing in older adults: current status and future research. J Am Geriatr Soc. 2015 Mar; 63(3):427-38. PMID: 25753048; PMCID: PMC4582412; DOI: 10.1111/jgs.13332;.
  9. Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH, Thom S, Tomic-Canic M, Walston J, Whitney J, Williams J, Zieman S, Schmader K. Chronic wound repair and healing in older adults: current status and future research. Wound Repair Regen. 2015 Jan-Feb; 23(1):1-13. PMID: 25486905; PMCID: PMC4414710; DOI: 10.1111/wrr.12245;.
  10. Carson P, Hong CJ, Otero-Vinas M, Arsenault EF, Falanga V. Liver enzymes and lipid levels in patients with lipodermatosclerosis and venous ulcers treated with a prototypic anabolic steroid (stanozolol): a prospective, randomized, double-blinded, placebo-controlled trial. Int J Low Extrem Wounds. 2015 Mar; 14(1):11-8.View Related Profiles. PMID: 25652757; DOI: 10.1177/1534734614562276;.
Showing 10 of 318 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 318 publications over 35 distinct years, with a maximum of 26 publications in 1993

YearPublications
19811
19842
19855
19865
19877
198810
198914
199011
199122
199211
199326
19948
199513
199612
19979
199817
199910
200015
200111
200216
200317
20049
20056
20068
20078
20088
20096
20104
20112
20126
20136
20143
20153
20166
20171

Available to Mentor as: (Review Mentor Role Definitions):
  • Education Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:


25 Buick St
Boston MA 02215
Google Map


Falanga's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department